Telehealth Depression Prescribing: What Prescribers Can Do in Michigan

If you’re a psychiatrist or PMHNP considering telehealth for depression treatment, you’ve probably asked yourself: Can I legally prescribe antidepressants over video? What about across state lines? Will I get paid the same as in-person visits?

The short answer: Yes, you can prescribe depression medications via telehealth — and in most cases, you’ll be reimbursed at the same rate as office visits. But the details matter, especially when it comes to state licensing, scope of practice, and which medications you can prescribe remotely.

Here’s what every prescriber needs to know about managing depression through telehealth in 2026.

Why Depression Treatment Fits Telehealth So Well

Depression medication management is one of the most telehealth-friendly areas of psychiatry. Here’s why:

Most antidepressants aren’t controlled substances. SSRIs, SNRIs, bupropion, mirtazapine — these first-line medications have no special federal prescribing restrictions. Unlike ADHD stimulants or chronic pain medications, you don’t need an in-person exam to start someone on Lexapro or Zoloft via telehealth.

Mental status exams translate well to video. You can assess mood, affect, speech, thought process, and suicide risk through a secure video platform just as effectively as in an office.

Frequent follow-ups are easier. Best practice for depression management often involves check-ins every 2-4 weeks when starting or adjusting medications. Telehealth makes these brief visits far more accessible for patients — no commute, no time off work, better adherence.

The regulatory environment supports it. Telehealth behavioral health utilization remains 20+ times higher than pre-2019 levels, and payers have kept up. As of 2025, 44 states plus DC mandate private insurance coverage for telehealth, with 23 states requiring equal payment to in-person visits for the same services.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Rules: What You Can Prescribe via Telehealth

Non-Controlled Medications (No Restrictions)

For depression’s first-line treatments — SSRIs (fluoxetine, sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), atypical antidepressants (bupropion, mirtazapine) — there are zero additional federal restrictions for telehealth prescribing.

You can:

• Conduct an initial evaluation via video
• Diagnose major depressive disorder
• E-prescribe to the patient’s local pharmacy
• Manage follow-ups entirely remotely

The standard of care remains the same (thorough assessment, suicide screening, informed consent, documentation), but the medium doesn’t add regulatory hurdles.

Controlled Substances (Temporary Flexibility Extended)

What about when you need to prescribe a benzodiazepine for severe anxiety comorbid with depression? Or a sleep aid for insomnia symptoms?

The Ryan Haight Act normally requires an in-person medical evaluation before prescribing controlled substances. But COVID-era waivers changed that — and those flexibilities have been extended through December 31, 2025 (and likely beyond, given ongoing bipartisan support).

This means you can currently prescribe Schedule II-V controlled substances via telehealth without a prior in-person visit, as long as:

• You conduct a synchronous audio-video evaluation
• You establish a legitimate patient-provider relationship
• You document appropriately and use e-prescribing/PDMP systems

For depression care, this is relevant when treating comorbid conditions (anxiety, insomnia) or using adjunctive medications. The DEA and HHS plan to release permanent telemedicine prescribing rules — most expect these to maintain at least some telehealth prescribing pathways for mental health.

Bottom line: As of 2026, psychiatrists can manage depression via telehealth with the full medication toolkit available, including controlled substances when clinically indicated.

State Licensing: The Real Gatekeeper

Here’s the most important rule: You must be licensed in the state where your patient is physically located during the telehealth visit.

This applies whether you’re in the same state, across the country, or even if the patient is traveling. State medical boards enforce this strictly.

For Psychiatrists (MD/DO):

You need a full medical license in each state where you treat patients. The Interstate Medical Licensure Compact (IMLC) makes this easier — 37 states participate, allowing expedited licensing across member states. If you’re interested in multi-state telepsychiatry, the Compact saves significant time and expense.

For PMHNPs:

State licensure requirements vary, and some states also participate in the Nurse Licensure Compact (NLC) for multi-state practice. However, scope of practice rules differ dramatically by state — which brings us to the most critical distinction between MDs and NPs in telehealth.

MD vs PMHNP Prescribing Authority: The State-by-State Reality

This is where telehealth prescribing gets complicated for nurse practitioners.

Psychiatrists have full prescriptive authority in all 50 states. Your medical license authorizes you to prescribe any medication within your scope, no supervision required.

PMHNPs face a patchwork of state laws that fall into three categories:

1. Full Practice Authority — NPs can evaluate, diagnose, and prescribe independently
2. Reduced Practice — NPs need a collaborative agreement with a physician for some aspects (often prescribing)
3. Restricted Practice — NPs require continuous physician supervision

State-by-State Breakdown for Depression Prescribing

New York: Full Practice (for experienced NPs)

As of 2022, New York eliminated collaborative agreement requirements for NPs with 3,600+ hours of practice. A PMHNP in New York can independently manage depression patients and prescribe antidepressants without physician oversight — functionally equivalent to an MD’s authority.

For telehealth platforms, this makes New York NPs highly recruitable with no administrative complexity.

Pennsylvania: Reduced Practice

Pennsylvania requires PMHNPs to maintain a collaborative agreement with a physician to prescribe. The physician doesn’t need to co-sign each prescription, but the legal framework requires documented oversight.

For an MD joining a telehealth platform in PA: no restrictions. For a PMHNP: the platform needs to arrange or verify a collaborating physician relationship.

Illinois: Reduced Practice (with FPA pathway)

Illinois allows experienced NPs (4,000+ hours supervised practice plus additional training) to obtain Full Practice Authority status, enabling them to prescribe independently — with one caveat: certain controlled substances (benzodiazepines, Schedule II drugs) still require a physician consultation agreement.

For depression medication management (non-controlled), an FPA-credentialed PMHNP in Illinois operates independently. For newer NPs without FPA status, a collaborative agreement is required.

California: Transitioning to Full Practice

California was historically one of the most restrictive states, requiring NPs to follow physician-developed ‘standardized procedures’ for prescribing. AB 890 (passed 2020) is phasing in independence:

• As of January 2023: Qualified NPs can practice without standardized procedures in certain healthcare settings (clinics, hospitals, group practices)
• Beginning January 2026: Experienced NPs can obtain Board certification for fully independent practice in any setting, including telehealth

By 2026, many California PMHNPs will prescribe depression medications independently. Until they obtain that certification, physician oversight remains required.

For telehealth recruiting: California is in transition — clarify each NP’s certification status.

Texas: Restricted Practice

Texas is among the most restrictive states for NP practice. PMHNPs must have a formal Prescriptive Authority Agreement with a supervising physician, including:

• Regular chart reviews (specific percentages mandated)
• Periodic face-to-face meetings with the supervising MD
• Physician delegation for all prescribing activities

A PMHNP cannot prescribe any medication — including routine antidepressants — without this oversight in place.

Additionally, Texas generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings.

For telepsychiatry in Texas: MDs have full autonomy; NPs require physician oversight. Given Texas’s severe psychiatrist shortage (approximately 1 psychiatrist per 9,000 residents), recruiting MDs may be strategically easier than arranging NP supervision.

A 2023 bill to grant Texas NPs full practice authority failed to pass.

Florida: Restricted Practice (partial autonomy)

Florida’s 2020 law created ‘autonomous APRN’ status — but only for primary care specialties, explicitly excluding psychiatric nurse practitioners.

PMHNPs in Florida must practice under a written protocol with a supervising physician. They can prescribe controlled substances under that protocol, with some restrictions (e.g., 7-day limit on Schedule II for acute pain).

For depression treatment, a Florida PMHNP can prescribe SSRIs and other antidepressants, but the legal framework requires documented physician oversight.

Florida also faces severe shortages (1 psychiatrist per 8,500 residents), making telepsychiatry a high-demand service — but NPs need supervisory arrangements in place.

What This Means for Your Telehealth Practice

If You’re a Psychiatrist:

Your biggest consideration is multi-state licensure. Once licensed in a state, you can:

• Conduct initial evaluations via video
• Prescribe any necessary medication (including controlled substances under current federal rules)
• Manage ongoing medication adjustments
• Bill insurance at the same rate as in-person visits

No collaborative agreements. No supervisory requirements. No formulary restrictions beyond standard prescribing guidelines.

The Interstate Medical Licensure Compact makes scaling to multiple states much more efficient than applying state-by-state.

If You’re a PMHNP:

Your scope depends entirely on your state(s) of practice.

In full practice states (New York, or California post-2026 with certification), you operate with physician-level prescribing autonomy for depression.

In reduced/restricted practice states (Pennsylvania, Illinois without FPA, Texas, Florida), you’ll need:

• A collaborative agreement or supervisory relationship with a physician
• Documentation of that relationship in your employment/platform contracts
• Awareness of any state-specific controlled substance limitations

Many telehealth platforms handle these arrangements — but clarity upfront prevents licensing issues.

Reimbursement: Will You Get Paid the Same?

Short answer: Yes, in most cases.

Telehealth Parity Laws

Thanks to pandemic-era policy changes that have largely been made permanent, telehealth behavioral health visits are reimbursed comparably to in-person care in the vast majority of states.

As of 2025:

• 44 states + DC require private insurers to cover telehealth
• 23 states mandate payment parity (equal rates for virtual and in-person visits)

States like New York and Illinois have explicit parity laws. Even states without statutory parity often see insurers voluntarily reimburse telehealth mental health at in-person rates, driven by the federal Mental Health Parity Act and ongoing demand for services.

Medicare Reimbursement

Medicare has extended telehealth flexibilities for behavioral health through at least the end of 2025 (and likely beyond). This includes:

• No geographic restrictions — patients can be anywhere, including their homes
• Same payment rates as in-person visits for E/M codes
• No requirement for a prior in-person visit (a requirement that was introduced then postponed)

For medication management visits, psychiatrists typically use:

• CPT 99214 (25-30 min, moderate complexity) — reimburses ~$120-$130 on average from private payers, ~$115 from Medicare
• CPT 99213 (15-20 min, low complexity) — reimburses ~$80-$100 private, ~$80 Medicare

One Medicare nuance: NPs are reimbursed at 85% of the physician fee schedule when billing under their own NPI. So for the same service, a psychiatrist receives 100% and an NP receives 85% under Medicare rules (42 CFR 414).

For telehealth platforms, this creates a small economic difference — but it’s far outweighed by the ability to expand capacity with NPs in states where they can practice independently.

Commercial Insurance

Major payers (Aetna, BCBS, UnitedHealthcare, Cigna) have maintained telehealth mental health coverage with strong reimbursement. The average reimbursement for a 99214 telehealth visit across major commercial payers is approximately $120-$130 — essentially identical to in-person rates.

Billing Best Practices

To ensure proper reimbursement:

• Use modifier 95 or GT to designate telehealth encounters
• Use Place of Service code 02 (telehealth) when required by the payer
• Document the encounter thoroughly (same standard of care as in-person)
• Ensure your platform meets HIPAA compliance and state telehealth technology requirements

Economic Reality Check: The Hidden Costs of DIY Patient Acquisition

Let’s talk about what most ‘build your own practice’ advice conveniently ignores: acquiring qualified psychiatric patients is expensive and time-consuming.

The Real Cost of Marketing a Private Practice

The conventional wisdom says: ‘Build your website, do some SEO, run Google Ads, list yourself on Psychology Today, and patients will come.’ Here’s what that actually costs:

SEO Investment:

• Professional SEO services: $1,500-$3,000/month minimum
• Content creation and technical optimization: $500-$1,000/month
• Timeline to results: 6-12 months before you see meaningful patient volume
• During that time: you’re paying monthly fees with zero guaranteed return

Google Ads:

• Cost per click for ‘psychiatrist near me’ or ‘depression treatment’: $15-40+
• Average conversion rate (click to booked appointment): 2-5%
• That means $300-$800+ per booked patient — and that’s before accounting for no-shows and unqualified leads

Directory Listings:

• Psychology Today: $30-40/month subscription, but you’re competing with hundreds of providers on the same search results page
• Zocdoc: Pay-per-booking model ($35-100+ per new patient) PLUS monthly subscription fees
• Total monthly directory spend: $100-200+ with highly variable results

The Hidden Costs:

• Agency/consultant fees to manage all this: $2,000-4,000/month
• Staff time to field inquiries, qualify leads, handle scheduling: 10-20 hours/week
• No-show rate from cold leads: 20-30% (you paid to acquire them, they ghost)
• Failed campaigns and wasted ad spend during ‘testing and optimization’: $1,000-2,000

Bottom Line: Acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ when you factor in all expenses — and that’s only if you have the expertise, budget, and patience to get the systems working. Most solo providers don’t.

The Klarity Model: Pay Only for Patients You See

Here’s the difference with a platform like Klarity Health:

No upfront marketing costs. Zero monthly subscriptions. No agency retainers. No ad spend gambling.

Pay-per-appointment model. You pay a standard listing fee only when a pre-qualified patient books with you. The patient has already been matched to your specialty, verified for insurance/cash-pay capacity, and scheduled into your availability.

Guaranteed ROI. Instead of spending $3,000-5,000/month on marketing with uncertain results, you know exactly what each patient costs — and you only pay when you actually deliver care.

Built-in infrastructure. The platform handles:

• Patient acquisition and qualification
• Telehealth technology (no separate platform subscription)
• Insurance verification and billing support
• Both insurance and cash-pay patient flow
• Schedule management (you control your availability)

What this means economically: If you see 20 new patients in a month through Klarity and pay a $75 listing fee per patient, your patient acquisition cost is $75 per patient — with zero wasted spend, zero staff time fielding unqualified leads, and zero risk.

Compare that to spending $3,500/month on marketing to acquire those same 20 patients ($175 per patient) — with no guarantee you’d even reach 20, and months of investment before seeing results.

Why This Matters for Depression Treatment Specifically

Depression patients need consistency and follow-up. The value isn’t just the initial evaluation — it’s the ongoing medication management relationship (4-6+ visits in the first year, then quarterly or as-needed).

If you acquire a depression patient for $75 through Klarity and manage their care for a year with 6 follow-up visits at $120 reimbursement each, your patient lifetime value is $720 — minus the $75 acquisition cost, that’s $645 net per patient.

If you spend $400 in Google Ads to acquire that same patient (and that’s assuming your campaigns are optimized), your net drops to $320 per patient — less than half.

The economic case for a platform model isn’t about avoiding marketing entirely. It’s about removing the risk and inefficiency of DIY patient acquisition so you can focus on what you’re actually trained to do: treat patients.

Frequently Asked Questions

Can I prescribe antidepressants to a new patient I’ve never met in person?

Yes, via synchronous video telehealth. Most states accept that a video evaluation establishes a valid patient-provider relationship for prescribing non-controlled medications. You must conduct a thorough assessment, document appropriately, and meet the standard of care — but no in-person visit is required for initiating SSRIs, SNRIs, or other antidepressants.

What about prescribing benzodiazepines or sleep medications for depression patients?

Under current federal rules (extended through end of 2025 and likely beyond), you can prescribe controlled substances via telehealth after a video evaluation, without a prior in-person visit. This applies to benzodiazepines (for anxiety comorbid with depression) and Schedule IV sleep aids. Always check your state’s specific rules — some states have additional requirements for controlled substance prescribing, even in mental health.

Do I need separate DEA registrations for each state where I prescribe?

Yes. You need a DEA registration in each state where you prescribe controlled substances. For non-controlled medications (most antidepressants), only state medical licensure is required. The DEA has an online registration system, and fees are ~$888 for three years per registration.

Will insurance reimburse telehealth visits at the same rate as in-person?

In most states, yes. Telehealth parity laws in 23 states mandate equal payment, and even in states without explicit parity, major insurers typically reimburse behavioral health telehealth at in-person rates. Medicare also pays the same rate for telehealth mental health visits through at least 2025. Always verify with your specific payers, but the trend strongly favors parity for psychiatric services.

As a PMHNP, do I need a collaborating physician if I only prescribe non-controlled medications?

That depends on your state. In full practice states (New York, or California with certification), no — you can prescribe independently. In reduced or restricted practice states (Pennsylvania, Illinois without FPA, Texas, Florida), yes — you need a collaborative agreement or supervisory relationship with a physician to prescribe ANY medications, including non-controlled antidepressants. The restriction isn’t about the medication class; it’s about your scope of practice in that state.

Can I treat patients across state lines via telehealth?

Only if you hold active licenses in both states (yours and the patient’s). The patient’s physical location during the telehealth visit determines which state’s laws apply. Multi-state practice requires either obtaining licenses in each state individually or participating in licensure compacts (IMLC for physicians, NLC for nurses where applicable). Many telepsychiatrists obtain 3-5 state licenses to expand their patient reach.

How do I handle emergency situations or suicidal ideation in telehealth?

You follow the same clinical protocols as in-person: conduct thorough suicide risk assessments, develop safety plans, coordinate with local emergency services if needed, and document everything. Most telehealth platforms provide resources like local crisis line numbers and procedures for contacting emergency services in the patient’s location. Telehealth doesn’t change your duty of care — if a patient is at imminent risk, you facilitate immediate in-person evaluation (ER, mobile crisis team, or local provider).

The Bottom Line: Telehealth Depression Treatment is Here to Stay

For psychiatrists and PMHNPs, telehealth has moved from emergency pandemic stopgap to permanent, well-reimbursed care delivery model.

The regulations support it. The economics work. And most importantly, patients desperately need it — especially in shortage states like Texas and Florida where accessing a psychiatrist can take months.

If you’re considering telehealth:

You can legally prescribe depression medications remotely (and most other psychiatric meds under current federal rules)

Reimbursement matches in-person rates in the vast majority of cases

Your scope depends on your credential and state — MDs have full autonomy everywhere; NPs need to verify their state’s practice authority

Licensing in multiple states unlocks significant patient access — consider the Interstate Medical Licensure Compact

Traditional marketing is expensive and risky — platforms that pre-qualify patients and handle acquisition remove that burden entirely

Ready to Treat Depression Patients via Telehealth?

Klarity Health connects psychiatrists and PMHNPs with patients who need medication management for depression, anxiety, and other conditions — without the overhead of building a practice from scratch.

No upfront marketing costs. No monthly subscriptions. Just qualified patients matched to your schedule.

You set your availability. We handle patient acquisition, telehealth technology, and billing support. You focus on what you do best: treating patients.

Whether you’re looking to supplement your in-person practice, transition fully to telehealth, or expand to new states, Klarity provides the infrastructure and patient flow to make it sustainable.

Explore joining Klarity’s provider network and start seeing patients who need your expertise — without gambling thousands on marketing campaigns that may or may not work.

References and Citations

1. California Legislature. (2020). Assembly Bill No. 890: Nurse practitioners: scope of practice. Retrieved from https://www.leginfo.legislature.ca.gov

2. Florida Legislature & Nursing Association. (2020). House Bill 607: Autonomous Advanced Practice Registered Nurse Practice. Retrieved from https://www.flanp.org

3. American Association of Nurse Practitioners. (2024). State Practice Environment: Texas. Retrieved from https://www.aanp.org

4. Rivkin Radler LLP. (2022). New Law Allows Experienced NPs to Practice Without Collaborative Agreement in New York. JD Supra. Retrieved from https://www.jdsupra.com

5. Texas Nurse Practitioners. (2023). DEA Extends Telemedicine Prescribing Flexibilities Through December 2024. Retrieved from https://texasnp.org

Source:

• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.aanp.org/advocacy/texas#:~:text=Regulatory%20Structure
• https://www.flanp.org/page/PastNewLaws#:~:text=must%20engage%20in%20such%20practice,is%20composed%20of%209%20members
• https://texasnp.org/news-laws-and-regulations/#:~:text=,or%20before%20November%2011%2C%202023
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,controlled%20substances%20like%20Adderall%20without
• https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890#:~:text=education%2C%20experience%2C%20and%20certification%20requirements,The%20bill%20would%20require%20the
• https://www.icanotes.com/2022/03/09/telehealth-parity-laws/#:~:text=reports%20that%2044%20states%2C%20the,or%20limitations%20in%20their%20implementation
• https://payerprice.com/rates/99214-CPT-fee-schedule#:~:text=National%20average%20reimbursement%20for%20CPT,99214%20by%20major%20payers
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=42%20%20,9%2C318
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=43%20%20,9%2C327